Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Korean Open-label Adjunctive Zonisamide Trial in Uncontrolled Partial Epilepsy
2016-004958-14Phase 4
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zonisamide in epilepsy, sponsored by Eisai Co., Ltd. Primary endpoint: Seizure Reduction Rate.
02
Drugs
zonisamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2016-004958-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004958-14.